CMM, a paraptosis agent composed of copper ions (Cu2+), morusin, and NLG919 (an indoleamine 2,3-dioxygenase (IDO) inhibitor), was found to induce immunogenic cell death in tumor cells, characterized by extensive vacuolization of the ER and mitochondria. The gene discussed is IDO2; the disease is neoplasm.